Xiaolin Zhang

Xiaolin Zhang is currently an Associate Principal Scientist at Merck, where they have demonstrated expertise in late-stage commercial process development and cell culture optimization. Prior to this role, they served as a Senior Scientist at Merck from 2018 to 2022, contributing to process characterization and successful scale-ups. Xiaolin previously worked as a Postdoctoral Researcher at the University of Delaware from 2015 to 2018, focusing on solving production instability issues in CHO cells. Their academic journey includes a PhD in System Biology/Metabolic Engineering from the University of Wisconsin-Madison, where they also conducted research as a Research Assistant, designing E. coli strains for chemical production with notable successes and a patent approval.